Half-year report · HY

Period2025-12-01 → 2026-05-31
Filed2026-07-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥4.3bn2025-12-01 → 2026-05-31Cons.Net sales
Revenue¥8.8bn2024-12-01 → 2025-11-30Cons.Net sales (5-year summary)
Revenue¥4.3bn2024-12-01 → 2025-05-31Cons.Net sales
Operating income¥304m2025-12-01 → 2026-05-31Cons.Operating income
Operating income¥199m2024-12-01 → 2025-05-31Cons.Operating income
Ordinary income¥285m2025-12-01 → 2026-05-31Cons.Ordinary income
Ordinary income¥405m2024-12-01 → 2025-11-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥183m2024-12-01 → 2025-05-31Cons.Ordinary income
Profit before tax¥288m2025-12-01 → 2026-05-31Cons.Income before income taxes
Profit before tax¥183m2024-12-01 → 2025-05-31Cons.Income before income taxes
Net income (owners)¥209m2025-12-01 → 2026-05-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥298m2024-12-01 → 2025-11-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥135m2024-12-01 → 2025-05-31Cons.Profit loss attributable to owners of parent
Net income¥209m2025-12-01 → 2026-05-31Cons.Profit loss
Net income¥135m2024-12-01 → 2025-05-31Cons.Profit loss
Total assets¥9.0bnat 2026-05-31Cons.Assets
Total assets¥8.9bnat 2025-11-30Cons.Assets
Total assets¥8.8bnat 2025-05-31Cons.Total assets (5-year summary)
Total liabilities¥5.7bnat 2026-05-31Cons.Liabilities
Total liabilities¥5.7bnat 2025-11-30Cons.Liabilities
Net assets / equity¥3.3bnat 2026-05-31Cons.Net assets
Net assets / equity¥3.1bnat 2025-11-30Cons.Net assets
Net assets / equity¥2.9bnat 2025-05-31Cons.Net assets (5-year summary)
Cash and deposits¥2.0bnat 2026-05-31Cons.Cash and deposits
Cash and deposits¥1.2bnat 2025-11-30Cons.Cash and deposits
Cash & equivalents¥2.0bnat 2026-05-31Cons.Cash and cash equivalents
Cash & equivalents¥1.2bnat 2025-11-30Cons.Cash and cash equivalents
Cash & equivalents¥1.3bnat 2025-05-31Cons.Cash and cash equivalents
Cash & equivalents¥745mat 2024-11-30vCons.Cash and cash equivalents
Operating cash flow¥1.1bn2025-12-01 → 2026-05-31Cons.Net cash provided by used in operating activities
Operating cash flow¥830m2024-12-01 → 2025-11-30Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥566m2024-12-01 → 2025-05-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥138m2025-12-01 → 2026-05-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥739m2024-12-01 → 2025-11-30Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥216m2024-12-01 → 2025-05-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥228m2025-12-01 → 2026-05-31Cons.Net cash provided by used in financing activities
Financing cash flow¥360m2024-12-01 → 2025-11-30Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥187m2024-12-01 → 2025-05-31Cons.Net cash provided by used in financing activities
EPS (basic)¥171.922025-12-01 → 2026-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥245.112024-12-01 → 2025-11-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥110.522024-12-01 → 2025-05-31Cons.Basic earnings loss per share (5-year summary)
Equity ratio36.6%at 2026-05-31Cons.Equity to asset ratio (5-year summary)
Equity ratio35.3%at 2025-11-30Cons.Equity to asset ratio (5-year summary)
Equity ratio33.5%at 2025-05-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
Pharmaceutical Productsreportable segmentrevenue2025-12-01 → 2026-05-31¥4.3bn
Pharmaceutical Productsreportable segmentrevenue external2025-12-01 → 2026-05-31¥4.3bn
Pharmaceutical Productsreportable segmentsegment profit2025-12-01 → 2026-05-31¥288m
Real Estate Leasingreportable segmentrevenue2025-12-01 → 2026-05-31¥19m
Real Estate Leasingreportable segmentrevenue external2025-12-01 → 2026-05-31¥19m
Real Estate Leasingreportable segmentsegment profit2025-12-01 → 2026-05-31¥15m
Total Of Reportable Segments And Otherssegment totalrevenue2025-12-01 → 2026-05-31¥4.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2025-12-01 → 2026-05-31¥4.3bn
Total Of Reportable Segments And Otherssegment totalsegment profit2025-12-01 → 2026-05-31¥304m
Pharmaceutical Productsreportable segmentrevenue2024-12-01 → 2025-05-31¥4.3bn
Pharmaceutical Productsreportable segmentrevenue external2024-12-01 → 2025-05-31¥4.3bn
Pharmaceutical Productsreportable segmentsegment profit2024-12-01 → 2025-05-31¥184m
Real Estate Leasingreportable segmentrevenue2024-12-01 → 2025-05-31¥19m
Real Estate Leasingreportable segmentrevenue external2024-12-01 → 2025-05-31¥19m
Real Estate Leasingreportable segmentsegment profit2024-12-01 → 2025-05-31¥15m
Total Of Reportable Segments And Otherssegment totalrevenue2024-12-01 → 2025-05-31¥4.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2024-12-01 → 2025-05-31¥4.3bn
Total Of Reportable Segments And Otherssegment totalsegment profit2024-12-01 → 2025-05-31¥199m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 480
ItemContextValueUnit
Other noePrior1InterimDuration69000JPY
Other noeInterimDuration67000JPY
Non operating expensesPrior1InterimDuration23502000JPY
Non operating expensesInterimDuration25845000JPY
Ordinary incomePrior1InterimDuration183335000JPY
Ordinary incomeInterimDuration285352000JPY
Gain on sales of investment securities eiPrior1InterimDuration-JPY
Gain on sales of investment securities eiInterimDuration2691000JPY
Extraordinary incomePrior1InterimDuration-JPY
Extraordinary incomeInterimDuration2691000JPY
Loss on retirement of noncurrent assets elPrior1InterimDuration233000JPY
Loss on retirement of noncurrent assets elInterimDuration15000JPY
Extraordinary lossPrior1InterimDuration233000JPY
Extraordinary lossInterimDuration15000JPY
Income before income taxesPrior1InterimDuration183101000JPY
Income before income taxesInterimDuration288029000JPY
Income taxes currentPrior1InterimDuration41018000JPY
Income taxes currentInterimDuration45918000JPY
Income taxes deferredPrior1InterimDuration7535000JPY
Income taxes deferredInterimDuration32816000JPY
Income taxesPrior1InterimDuration48554000JPY
Income taxesInterimDuration78734000JPY
Profit lossPrior1InterimDuration134547000JPY
Profit lossInterimDuration209294000JPY
Profit loss attributable to non controlling interestsPrior1InterimDuration-JPY
Profit loss attributable to non controlling interestsInterimDuration-JPY
Profit loss attributable to owners of parentPrior1InterimDuration134547000JPY
Profit loss attributable to owners of parentInterimDuration209294000JPY
Profit lossPrior1InterimDuration134547000JPY
Profit lossInterimDuration209294000JPY
Valuation difference on available for sale securities net of tax ociPrior1InterimDuration2408000JPY
Valuation difference on available for sale securities net of tax ociInterimDuration7558000JPY
Foreign currency translation adjustment net of tax ociPrior1InterimDuration-7985000JPY
Foreign currency translation adjustment net of tax ociInterimDuration18285000JPY
Other comprehensive incomePrior1InterimDuration-5577000JPY
Other comprehensive incomeInterimDuration25843000JPY
Comprehensive incomePrior1InterimDuration128969000JPY
Comprehensive incomeInterimDuration235137000JPY
Comprehensive income attributable to owners of the parentPrior1InterimDuration128969000JPY
Comprehensive income attributable to owners of the parentInterimDuration235137000JPY
Comprehensive income attributable to non controlling interestsPrior1InterimDuration-JPY
Comprehensive income attributable to non controlling interestsInterimDuration-JPY
Income before income taxesPrior1InterimDuration183101000JPY
Income before income taxesInterimDuration288029000JPY
Depreciation and amortization ope cfPrior1InterimDuration197749000JPY
Depreciation and amortization ope cfInterimDuration225363000JPY
Increase decrease in allowance for doubtful accounts ope cfPrior1InterimDuration-631000JPY
Increase decrease in allowance for doubtful accounts ope cfInterimDuration-1936000JPY
Increase decrease in net defined benefit asset ope cfPrior1InterimDuration-JPY
Increase decrease in net defined benefit asset ope cfInterimDuration-91692000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2025-11-30pass rounding
balance sheet identityconsolidated 2026-05-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2025-11-30pass
statement vs summary · net assetsconsolidated 2026-05-31pass
statement vs summary · net income attributable to parentconsolidated 2024-12-01/2025-05-31pass
statement vs summary · net income attributable to parentconsolidated 2025-12-01/2026-05-31pass
statement vs summary · operating cash flowconsolidated 2024-12-01/2025-05-31pass
statement vs summary · operating cash flowconsolidated 2025-12-01/2026-05-31pass
statement vs summary · revenueconsolidated 2024-12-01/2025-05-31pass
statement vs summary · revenueconsolidated 2025-12-01/2026-05-31pass
statement vs summary · total assetsconsolidated 2025-11-30pass
statement vs summary · total assetsconsolidated 2026-05-31pass